SKVARKA JAN received a stock award from ZENTALIS PHARMACEUTICALS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 6/21/2024ACC: 0001725160-24-000145
Director
Since Sep 2022
+41.58K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
41.58K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+41.58K
Price / share
—
Trade value
—
% of position
86.7%
6/21/2024
47.97K→89.55K
Total
Net shares
+41.58K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/21/2024 | A · Award | +41.58K | — | — | 86.7% | 47.97K | 89.55K |
| Total | +41.58K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported